SUNNYVALE, Calif., Aug 7th, 2014 - Apurba Technologies Ltd., a Sunnyvale, CA, based software development company that creates enterprise data solutions for data processing, visualization and analytics, announced today that Dr. Marvin Slepian has joined the company as Senior Strategic Adviser.
Marvin J. Slepian, M.D is the Co-Founder and Chief Scientific Officer of SynCardia Systems Inc., the owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.
Dr. Slepian is also the Founder and Director of ACABI - The Arizona Center for Accelerated Biomedical Innovation. He is a McGuire Scholar, Eller College of Management and a Professor of Medicine (Cardiology), Director of Interventional Cardiology and Director of the Tissue Engineering Lab at the University of Arizona.
Dr. Slepian has founded numerous medical device companies, including Focal (NASDAQ-traded, acquired by Genzyme), Endotex, Angiotrax and Hansen Medical, and has served as acting CEO and Board Member of several medical device startups.
He earned his A.B. in Biochemical Sciences and Science in Human Affairs from Princeton University, and his M.D. from the University of Cincinnati College of Medicine. He has received additional post-doctoral training at MIT and Washington University. Dr. Slepian completed his Internal Medicine training at NYU-Bellevue in New York where he was a Resident and Chief Resident in Medicine. He completed his Cardiology training at Johns Hopkins where he was a Clinical and Research Fellow. He completed a second fellowship in Interventional Cardiology at Cleveland Clinic.
"Mavin is a global leader in medical devices and health analytics, not to mention a widely successful entrepreneur," said Fuad Rahman, PhD, CEO of Apurba Technologies Ltd, "with Apurba’s analytics solutions being aggressively marketed to healthcare systems, we welcome his guidance in helping Apurba fill a growing demand in this sector."